Peloton Therapeutics

Home » Peloton Therapeutics

IPO

Peloton Therapeutics

We are a clinical stage biopharmaceutical company focused on translating novel scientific insights into first-in-class medicines for patients with cancer and other debilitating or life-threatening conditions.

Symbol

PLTX

Price Range
$15.00 - $17.00

Final Shares
9,375,000

Effective Date
May 23, 2019

Underwriters
J.P. MORGAN SECURITIES LLC, CITIGROUP GLOBAL MARKETS INC.

To view the prospectus for Peloton Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253